Innomar Strategies Revenue and Competitors
Estimated Revenue & Valuation
- Innomar Strategies's estimated annual revenue is currently $402.8M per year.
- Innomar Strategies's estimated revenue per employee is $201,000
Employee Data
- Innomar Strategies has 2004 Employees.
- Innomar Strategies grew their employee count by 1% last year.
Innomar Strategies's People
Name | Title | Email/Phone |
---|---|---|
1 | Senior Legal Counsel & Assistant Privacy Officer | Reveal Email/Phone |
2 | VP & Chief Canadian Counsel, Law Department | Reveal Email/Phone |
3 | VP, Specialty Operations | Reveal Email/Phone |
4 | VP, Enterprise Excellence | Reveal Email/Phone |
5 | VP, Consulting and Business Development | Reveal Email/Phone |
6 | VP, Business Transformation & IT | Reveal Email/Phone |
7 | Director, Programs | Reveal Email/Phone |
8 | Director QA GMP | Reveal Email/Phone |
9 | Commercialization Director | Reveal Email/Phone |
10 | Senior Director, Specialty Programs | Reveal Email/Phone |
Innomar Strategies Competitors & AlternativesAdd Company
Competitor Name | Revenue | Number of Employees | Employee Growth | Total Funding | Valuation |
---|---|---|---|---|---|
#1 | $6.8M | 34 | -41% | N/A | N/A |
#2 | $88M | 438 | 9% | N/A | N/A |
#3 | $86.8M | 432 | 24% | N/A | N/A |
#4 | $53.1M | 264 | 0% | N/A | N/A |
#5 | $1.2M | 6 | 0% | N/A | N/A |
#6 | $14.3M | 71 | 6% | N/A | N/A |
#7 | $43.8M | 218 | 6% | N/A | N/A |
#8 | $2.2M | 11 | 0% | N/A | N/A |
#9 | $23.3M | 116 | 6% | N/A | N/A |
#10 | $36.2M | 180 | 31% | N/A | N/A |
What Is Innomar Strategies?
Patient assistance programs, infusion clinics and nursing services, specialty pharmacy services, specialty distribution and third party logistics, healthcare consulting, pharmacovigilance solutions Innomar Strategies, a part of AmerisourceBergen, is Canada's leading patient support provider for specialty pharmaceuticals. We deliver end-to-end support solutions to improve product access, increase supply chain efficiency and enhance patient care. Strategic consulting, patient assistance programs, nursing and clinical services, and specialty pharmacy and logistics are just a few of our key areas of specialization. We partner closely with manufacturers, healthcare providers, pharmacies and payers to ensure patients have consistent and reliable access to specialty medication. With our integrated approach and commitment to best-in-class care, Innomar Strategies ensures patients are supported throughout their treatment journey every step of the way. ==== Innomar Strategies, qui fait partie d'AmerisourceBergen, est le principal fournisseur de soutien aux patients pour les produits pharmaceutiques spécialisés au Canada. Nous offrons des solutions de soutien complètes pour améliorer l'accès aux produits, accroître l'efficacité de la chaîne d'approvisionnement et améliorer les soins aux patients. Conseils stratégiques, programmes d'aide aux patients, soins infirmiers et services cliniques, et pharmacie et logistique spécialisées ne sont que quelques-uns de nos principaux domaines de spécialisation. Nous collaborons étroitement avec les fabricants, les fournisseurs de soins de santé, les pharmacies et les payeurs pour que les patients aient un accès constant et fiable aux médicaments spécialisés. Grâce à notre approche intégrée et engagement aux meilleurs soins, Innomar Strategies s'assure que les patients sont pris en charge tout au long de leur parcours de traitement, à chaque étape.
keywords:N/AN/A
Total Funding
2004
Number of Employees
$402.8M
Revenue (est)
1%
Employee Growth %
N/A
Valuation
N/A
Accelerator
Innomar Strategies News
... Edgetech, Sonardyne International Ltd., Innomar Technologie Gmbh, Ixblue Sas, ... Creating company strategies and elements that will aid in Hydrographic...
... Mawdsley-Brooks; Innomar Strategies; Johnson & Johnson; Sisters of Mercy Health System; Mayo Clinic; China National Pharmaceutical Group...
Company Name | Revenue | Number of Employees | Employee Growth | Total Funding |
---|---|---|---|---|
#1 | $300M | 2136 | 7% | N/A |
#2 | $627.8M | 2220 | 2% | N/A |
#3 | $452.6M | 2309 | 6% | N/A |
#4 | $1637.5M | 4332 | N/A | N/A |
#5 | $2093.6M | 8308 | N/A | N/A |